Pharmacological Control of Antigen Responsiveness in Genetically Modified T Lymphocytes

Journal of Immunology

Volumn 159, Issue 12, 1997, Pages 5889-5895

  Alvarez Vallina, Luis ^a,b   Agha Mohammadi, Siamak ^a   Hawkins, Robert E ^a   Russell, Stephen J ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b MRC CENTRE FOR PROTEIN ENGINEERING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTIGEN T CELL RECEPTOR, ZETA CHAIN; HYBRID PROTEIN; IMMEDIATE EARLY PROTEIN; IMMUNOGLOBULIN FRAGMENT; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; TETRACYCLINE; TRANSACTIVATOR PROTEIN;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; CYTOMEGALOVIRUS; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; SYNTHESIS; T LYMPHOCYTE;

ANTIGENS; CYTOMEGALOVIRUS; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TETRACYCLINE; TRANS-ACTIVATORS;

EID: 0031573555     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Mule, J. J., S. Shu, S. L. Schwarz, and S. R. Rosenberg. 1984. Adoptive immunotherapy of established pulmonary metastasis with LAK cells and recombinant interleukin-2. Science 225:1487.
2. Rosenberg, S. A., P. Spiess, and R. Lafreniere. 1986. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233:1318.
3. Eshhar, Z., T. Waks, G. Gross, and D. G. Schindler. 1993. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ζ subunits of the immunoglobulin and T-cell receptors. Proc. Natl. Acad. Sci. USA 90:720.
4. Hwu, P., G. E. Shafer, J. Treisman, D. G. Schindler, G. Gross, R. Cowherd, S. A. Rosenberg, and Z. Eshhar. 1993. Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor γ chain. J. Exp. Med. 178:361.
5. Stancovski, I., D. G. Schindler, T. Waks, Y. Yarden, M. Sela, and Z. Eshhar. 1993. Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors. J. Immunol. 151:6577.
6. Brocker, T., M. Riedinger, and K. Karjalainen. 1996. Redirecting the complete T cell receptor/CD3 signaling machinery towards native antigens via modified T cell receptor. Eur. J. Immunol. 26:1770.
7. Pardoll, D. 1994. Cancer. Curr. Opin. Immunol. 6:705.
8. Yarranton, G. T. 1992. Inducible vectors for expression in mammalian cells. Curr. Opin. Biotechnol. 3:506.
9. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547.
10. Gossen, M., A. L. Bonin, and H. Bujard. 1993. Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biol. Sci. 18:471.
11. Spits, H., H. Yssel, J. Leeuwenberg, and J. E. De Vries. 1985. Antigen-specific cytotoxic T cell and antigen-specific proliferating T cell clones can be induced to cytolytic activity by monoclonal antibodies against T3. Eur. J. Immunol. 15:88.
12. Alvarez-Vallina, L., and R. E. Hawkins. 1996. Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody fragment-CD28 receptors. Eur. J. Immunol. 26:2304.
13. Patten, P. A., E. P. Rock, T. Sonoda, B. Fazekas de St. Groth, I. L. Jorgensen, and M. M. Davis. 1992. Transfer of putative complementary-determining region loops of T cell receptor V domains confers toxin reactivity but not peptide/MHC specificity. J. Immunol. 150:2281.
14. Alvarez-Vallina, L., A. González, F. Gambón, M. Kreisler and F. Dïaz-Espada. 1993. Delimitation of the proliferative stages in the human thymus indicates that cell expansion occurs before the expression of CD3 (T cell receptor). J. Immunol. 150:8.
15. Hawkins, R. E., S. J. Russell, and G. Winter. 1992. Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J. Mol. Biol. 226:889.
16. Weissman, A. M., D. Hou, D. G. Orloff, W. S. Modi, H. Seuanez, S. J. O'Brien, and R. D. Klausner. 1988. Molecular cloning and chromosomal localization of the human T-cell receptor ζ chain: Distinction from the molecular CD3 complex. Proc. Natl. Acad. Sci. USA 85:9709.
17. Kloppenburg, M., C. L. Verweij, A. M. M. Miltenburg, A. J. Verhoeven, M. R. Daha, B. A. C. Dijkmans, and F. C. Breedveld. 1995. The influence of tetracyclines on T cell activation. Clin. Exp. Immunol. 102:635.
18. Hofmann, A., G. P. Nolan, and H. M. Blau. 1996. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc. Natl. Acad. Sci. USA 93:5185.
19. Ono, S., H. Ohno, and T. Saito. 1995. Rapid turnover of the CD3ζ chain independent of the TCR-CD3 complex in normal T cells. Immunity 2:639.
20. Agha-Mohammadi, S., L. Alvarez-Vallina, L. J. Ashworth, and R. E. Hawkins. 1997. Delay in resumption of the activity of tetracycline-regulatable promoter following removal of tetracycline analogues. Gene Ther. 4:993.
21. Houin, G., F. Brunner, Th. Nebout, M. Cherfaoui, G. Lagrue, and J. P. Tillement. 1983. The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man. Br. J. Clin. Pharmacol. 16:245.
22. Valitutti, S., S. Müller, M. Cella, E. Padovan, and A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148.
23. Valitutti, S., and A. Lanzavecchia. 1996. Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol. Today 6:299.
24. Shockett, P. E., and D. G. Schatz. 1996. Diverse strategies for teracycline-regulated inducible gene expression. Proc. Natl. Acad. Sci. USA 93:5173.
25. Ackland-Berlund, C. E., and D. A. Leib. 1995. The efficacy of tetracycline-controlled gene expression is influenced by cell type. Biotechniques 18:196.
26. Shockett, P., M. Difilippantonio, N. Hellman, and D. G. Schatz. 1995. A modified tetracycline-regulated system provide autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc. Natl. Acad. Sci. USA 92:6522.
27. Agha-Mohammadi, S., and R. E. Hawkins. 1997. Single tetracycline-controlled positive feedback regulatory system. Gene Ther. In press.